Encompass Health Co. (NYSE:EHC) Holdings Cut by Leeward Investments LLC MA

Leeward Investments LLC MA reduced its position in shares of Encompass Health Co. (NYSE:EHC) by 0.5% in the first quarter, Holdings Channel reports. The firm owned 550,066 shares of the company’s stock after selling 3,042 shares during the period. Encompass Health comprises approximately 2.0% of Leeward Investments LLC MA’s holdings, making the stock its 2nd biggest position. Leeward Investments LLC MA’s holdings in Encompass Health were worth $45,424,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. International Assets Investment Management LLC purchased a new position in Encompass Health in the fourth quarter worth $20,210,000. Jackson Creek Investment Advisors LLC boosted its holdings in shares of Encompass Health by 364.4% in the 4th quarter. Jackson Creek Investment Advisors LLC now owns 13,910 shares of the company’s stock worth $928,000 after purchasing an additional 10,915 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. increased its position in shares of Encompass Health by 2.3% during the 4th quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 1,318,784 shares of the company’s stock valued at $87,989,000 after purchasing an additional 29,926 shares during the last quarter. Phocas Financial Corp. lifted its position in Encompass Health by 112.4% in the 4th quarter. Phocas Financial Corp. now owns 99,875 shares of the company’s stock worth $6,664,000 after buying an additional 52,847 shares during the last quarter. Finally, TimesSquare Capital Management LLC boosted its stake in Encompass Health by 18.1% in the fourth quarter. TimesSquare Capital Management LLC now owns 1,150,866 shares of the company’s stock worth $76,786,000 after buying an additional 175,975 shares in the last quarter. Institutional investors own 97.25% of the company’s stock.

Insider Activity

In related news, CEO Mark J. Tarr sold 44,976 shares of Encompass Health stock in a transaction dated Tuesday, April 30th. The stock was sold at an average price of $83.27, for a total value of $3,745,151.52. Following the completion of the sale, the chief executive officer now directly owns 554,098 shares in the company, valued at approximately $46,139,740.46. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, insider Elissa Joy Charbonneau sold 10,000 shares of the firm’s stock in a transaction on Friday, May 24th. The stock was sold at an average price of $85.02, for a total value of $850,200.00. Following the transaction, the insider now directly owns 18,594 shares in the company, valued at approximately $1,580,861.88. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Mark J. Tarr sold 44,976 shares of the company’s stock in a transaction on Tuesday, April 30th. The shares were sold at an average price of $83.27, for a total value of $3,745,151.52. Following the sale, the chief executive officer now owns 554,098 shares of the company’s stock, valued at approximately $46,139,740.46. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 69,519 shares of company stock worth $5,816,091. Corporate insiders own 2.10% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have commented on EHC. Barclays lifted their price target on shares of Encompass Health from $101.00 to $108.00 and gave the stock an “overweight” rating in a research note on Thursday, April 25th. Royal Bank of Canada upped their price target on shares of Encompass Health from $83.00 to $95.00 and gave the company an “outperform” rating in a research report on Wednesday, May 22nd. Mizuho lifted their price objective on Encompass Health from $93.00 to $95.00 and gave the stock a “buy” rating in a report on Thursday, April 25th. Raymond James restated a “strong-buy” rating and set a $95.00 target price (up from $85.00) on shares of Encompass Health in a report on Friday, April 26th. Finally, Stephens restated an “overweight” rating and set a $94.00 price target on shares of Encompass Health in a research report on Wednesday, June 5th. Eight research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Encompass Health currently has a consensus rating of “Buy” and a consensus target price of $93.29.

Encompass Health Trading Up 0.5 %

NYSE:EHC traded up $0.47 during mid-day trading on Thursday, reaching $86.04. 547,774 shares of the company’s stock traded hands, compared to its average volume of 607,434. The company has a 50 day moving average price of $85.07 and a 200-day moving average price of $77.97. The firm has a market capitalization of $8.66 billion, a price-to-earnings ratio of 23.25, a PEG ratio of 1.33 and a beta of 0.89. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.37 and a quick ratio of 1.37. Encompass Health Co. has a 12-month low of $57.55 and a 12-month high of $87.94.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Wednesday, April 24th. The company reported $1.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.93 by $0.19. Encompass Health had a net margin of 7.60% and a return on equity of 18.01%. The company had revenue of $1.32 billion for the quarter, compared to analysts’ expectations of $1.27 billion. During the same quarter in the previous year, the company earned $0.88 earnings per share. Encompass Health’s quarterly revenue was up 13.4% on a year-over-year basis. On average, sell-side analysts predict that Encompass Health Co. will post 4.1 earnings per share for the current year.

Encompass Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, July 15th. Shareholders of record on Monday, July 1st will be given a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a yield of 0.70%. The ex-dividend date is Monday, July 1st. Encompass Health’s dividend payout ratio is currently 16.22%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.